Thursday, 5 November 2026European Markets

BEWI And TFF GROUP Have A High Dividend Yield And Return On Equity In The Packaging & Containers Industry.

Loading stream...

(vianews) - bewi (bewi.ol) is among this list of stock assets with the highest dividend rate and return on equity on the packaging & containers industry.

financial asset price forward dividend yield return on equity
bewi (bewi.ol) kr25.80 3.03% 1.23%
tff group (tff.pa) €46.00 1.44% 12.23%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. bewi (bewi.ol)

3.03% forward dividend yield and 1.23% return on equity

bewi asa provides packaging components and insulation solutions internationally. the company operates through raw, packaging & components (p&c), insulation & construction (i&c), and circular segments. the raw segment produces raw materials, including white and grey expanded polystyrene, general purpose polystyrene, and biofoam made from organic materials. the p&c segment manufactures and sells standard and customised solutions for various industrial sectors, including boxes for transportation of fish and other foods, protective packaging for fine goods, and technical and automotive components. the i&c segment manufactures a range of solutions for insulation and infrastructure, as well as systems for the building and construction industry. the circular segment collects and recycles used material, including initiatives to raise knowledge and awareness about recycling and waste management. the company sells its products to food, pharmaceutical, automotive, hobby and leisure, residential housing, and thermal insulation industries. the company was founded in 1980 and is headquartered in trondheim, norway. bewi asa is a subsidiary of bewi invest as.

earnings per share

as for profitability, bewi has a trailing twelve months eps of kr-1.25.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 1.23%.

sales growth

bewi's sales growth is negative 88.1% for the ongoing quarter and negative 89.6% for the next.

earnings before interest, taxes, depreciation, and amortization

bewi's ebitda is 11.89.

moving average

bewi's worth is way under its 50-day moving average of kr41.17 and way under its 200-day moving average of kr44.49.

dividend yield

as maintained by morningstar, inc., the next dividend payment is on nov 10, 2022, the estimated forward annual dividend rate is 1.1 and the estimated forward annual dividend yield is 3.03%.

more news about bewi.

2. tff group (tff.pa)

1.44% forward dividend yield and 12.23% return on equity

tff group, together with its subsidiaries, manufactures and distributes barrels and wood products for the aging of wines and alcohols in france, rest of europe, the united states, asia, and internationally. the company offers forestry and logging, stave milling, whisky and bourbon cooperages, cask making, wood and oenological products, and stainless-steel containers. it primarily serves wine, bourbon, and whisky markets. the company was formerly known as tonnellerie françois frères. tff group was founded in 1910 and is based in saint-romain-de-colbosc, france.

earnings per share

as for profitability, tff group has a trailing twelve months eps of €2.44.

pe ratio

tff group has a trailing twelve months price to earnings ratio of 18.85. meaning, the purchaser of the share is investing €18.85 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.23%.

more news about tff group.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,549 source documents archived
Query this data → isubstrate.com